Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk
- PMID: 20574778
- DOI: 10.1007/s11745-010-3439-7
Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk
Abstract
Dyslipidemias and physicochemical changes in low-density lipoprotein (LDL) are very important factors for the development of coronary artery disease (CAD). However, pathophysiological properties of electronegative low-density lipoprotein [LDL(-)] remain a controversial issue. Our objective was to investigate LDL(-) content in LDL and its subfractions (phenotypes A and B) of subjects with different cardiovascular risk. Seventy-three subjects were randomized into three groups: normolipidemic (N; n = 30) and hypercholesterolemic (HC; n = 33) subjects and patients with CAD (n = 10). After fasting, blood samples were collected and total, dense and light LDL were isolated. LDL(-) content in total LDL and its subfractions was determined by ELISA. LDL(-) content in total LDL was lower in the N group as compared to the HC (P < 0.001) and CAD (P = 0.006) groups. In the total sample and in those of the N, HC, and CAD groups, LDL(-) content in dense LDL was higher than in light LDL (P = 0.001, 0.001, 0.001, and 0.033, respectively) The impact of LDL(-) on cardiovascular risk was reinforced when LDL(-) content in LDL showed itself to have a positive association with total cholesterol (beta = 0.003; P < 0.001), LDL-C (beta = 0.003; p < 0.001), and non-HDL-C (beta = 0.003; P < 0.001) and a negative association with HDL-C (beta = -0.32; P = 0.04). Therefore, LDL(-) is an important biomarker that showed association with the lipid profile and the level of cardiovascular risk.
Similar articles
-
HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.Neuro Endocrinol Lett. 2011;32(4):502-9. Neuro Endocrinol Lett. 2011. PMID: 21876506 Clinical Trial.
-
Relation of oxidized-low-density lipoprotein and high-density lipoprotein subfractions in non-treated patients with coronary artery disease.Prostaglandins Other Lipid Mediat. 2019 Oct;144:106345. doi: 10.1016/j.prostaglandins.2019.106345. Epub 2019 Jul 3. Prostaglandins Other Lipid Mediat. 2019. PMID: 31278984
-
Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.Clin Chim Acta. 2015 Jun 15;446:195-200. doi: 10.1016/j.cca.2015.04.032. Epub 2015 Apr 28. Clin Chim Acta. 2015. PMID: 25934512
-
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.Am J Cardiol. 2002 Oct 17;90(8A):30i-47i. doi: 10.1016/s0002-9149(02)02749-2. Am J Cardiol. 2002. PMID: 12419479 Review.
-
Cardiovascular disease and dyslipidemia: beyond LDL.Curr Pharm Des. 2011;17(9):861-70. doi: 10.2174/138161211795428858. Curr Pharm Des. 2011. PMID: 21418031 Review.
Cited by
-
Opinion: On the Way towards the New Paradigm of Atherosclerosis.Int J Mol Sci. 2022 Feb 15;23(4):2152. doi: 10.3390/ijms23042152. Int J Mol Sci. 2022. PMID: 35216269 Free PMC article. Review.
-
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.Eur Heart J. 2020 Jun 21;41(24):2313-2330. doi: 10.1093/eurheartj/ehz962. Eur Heart J. 2020. PMID: 32052833 Free PMC article. No abstract available.
-
Effect of 405 nm low intensity irradiation on the absorption spectrum of in-vitro hyperlipidemia blood.Technol Health Care. 2018;26(S1):135-143. doi: 10.3233/THC-174302. Technol Health Care. 2018. PMID: 29710746 Free PMC article.
-
Green-banana biomass consumption by diabetic patients improves plasma low-density lipoprotein particle functionality.Sci Rep. 2020 Jul 23;10(1):12269. doi: 10.1038/s41598-020-69288-1. Sci Rep. 2020. PMID: 32704082 Free PMC article.
-
Effect of adjuvant probiotic therapy (Lactobacillus reuteri) in the treatment of periodontitis associated with diabetes mellitus: clinical, controlled, and randomized study.Clin Oral Investig. 2024 Jan 6;28(1):80. doi: 10.1007/s00784-023-05441-0. Clin Oral Investig. 2024. PMID: 38183505 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous